Helen Koenig, ACTHIV 2021: Antiretroviral Therapy for Treatment and Prevention of HIV

It was a pleasure to speak with Helen Koenig (MacGregor Infectious Diseases Clinic, Hospital of the University of Pennsylvania, Philadelphia, PA, USA) to discuss antiretroviral therapy for treatment and prevention of HIV.

The abstract entitled: ‘Antiretroviral Therapy for Treatment and Prevention’ was presented at the ACTHIV Virtual Conference 2021, May 20-22, 2021.

Questions:

1. What are the challenges in selecting and initiating HIV treatment regimen for a newly diagnosed patient, and how can they be overcome? (0:09)
2. What are the most common adverse effects and drug interactions associated with antiretroviral therapy (ART)? (2:03)
3. When and how should a change of ART be considered? (5:22)
4. Could you tell us a little about post exposure and pre-exposure prophylaxis (PEP and PrEP), and when they are indicated? (7:23)

Disclosures: Helen Koenig has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media. Interview filmed by Katey Gabrysch.

Filmed in coverage of the ACTHIV Virtual Conference 2021.